Medicine
Flunisolide 0.25 mg/mL nasal solution
Flunisolide 0.25 mg/mL nasal solution is a generic prescription medicine for nasal use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25ºC (68º to 77ºF), excursions permitted between 15º to 30ºC…
Key facts
- Active ingredient (INN)
- Flunisolide
- Brand
- Sold under the generic name
- Strength
- 0.25 mg/mL
- Dosage form
- Nasal solution
- Route
- Nasal
- Packs
- 1 bottle
- Manufacturers
- Bausch & LombIngenus PharmaceuticalsOceanside Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25ºC (68º to 77ºF), excursions permitted between 15º to 30ºC (59º to 86ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R01AD04 Flunisolide
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 February 2002
- Identifiers
- RxCUI 1797863DailyMed set ID f39cae46-c68f-47ef-82f3-4fd3dd46c74c, 50d87523-e1fb-4342-825f-9dba972c6a25, 7c72c954-3758-40c3-9977-d03b25d71e0aNDC 50742-317, 68682-344, 24208-344Application ANDA207802, ANDA074805
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, pump in 1 carton / 25 mL in 1 bottle, pump | 24208-344-25 | Bausch & Lomb | 20 February 2002 |
| 1 bottle, pump in 1 carton / 25 mL in 1 bottle, pump | 50742-317-25 | Ingenus Pharmaceuticals | 23 June 2022 |
| 1 bottle, pump in 1 carton / 25 mL in 1 bottle, pump | 68682-344-25 | Oceanside Pharmaceuticals | 1 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 24 September 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Flunisolide is a corticosteroid indicated for the treatment of the nasal symptoms of seasonal or perennial rhinitis. It is available as nasal solution. MedsAcross supplies Flunisolide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FlunisolideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Flunisolide prescribing information (Oceanside Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Flunisolide 0.25 mg/mL nasal solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.